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Polymer microchamber arrays for geometry-
controlled drug release: a functional study
in human cells of neuronal phenotype
Olga Kopach, a Kayiu Zheng,a Olga A. Sindeeva, b,c Meiyu Gai,b
Gleb B. Sukhorukov *b and Dmitri A. Rusakov *a
Polyelectrolyte multilayer (PEM) microchambers can provide a versatile cargo delivery system enabling
rapid, site-speciﬁc drug release on demand. However, experimental evidence for their potential beneﬁts
in live human cells is scarce. Equally, practical applications often require substance delivery that is
geometrically constrained and highly localized. Here, we establish human-cell biocompatibility and on-
demand cargo release properties of the PEM or polylactic acid (PLA)-based microchamber arrays fabri-
cated on a patterned ﬁlm base. We grow human N2A cells (a neuroblastoma cell line widely used for
studies of neurotoxicity) on the surface of the patterned microchamber arrays loaded with either a ﬂuo-
rescent indicator or the ubiquitous excitatory neurotransmitter glutamate. The diﬀerentiating human N2A
cells show no detrimental eﬀects on viability when growing on either PEM@PLA or PLA-based arrays for
up to ten days in vitro. Firstly, we use two-photon (2P) excitation with femtosecond laser pulses to open
individual microchambers in a controlled way while monitoring release and diﬀusion of the ﬂuorescent
cargo (rhodamine or FITC ﬂuorescent dye). Secondly, we document the increases in intracellular Ca2+ in
local N2A cells in response to the laser-triggered glutamate release from individual microchambers. The
functional cell response is site-speciﬁc and reproducible on demand and could be replicated by applying
glutamate to the cells using a pressurised micropipette. Time-resolved ﬂuorescence imaging conﬁrms
the physiological range of the glutamate-evoked intracellular Ca2+ dynamics in the diﬀerentiating N2A
cells. Our data indicate that the nano-engineering design of the fabricated PEM or PLA-based patterned
microchamber arrays could provide a biologically safe and eﬃcient tool for targeted, geometrically con-
strained drug delivery.
Introduction
Over the past decade, various nano-engineering designs have
been explored for their capability for micro-packaging, tar-
geted delivery, and controlled release of bioactive compounds.
Among such systems, the most prominent were nanoparticles
and microcapsules,1–3 hydrogels,4 and nanocomposite films
fabricated with the polyelectrolyte-based multilayer (PEM)
assembly using the layer-by-layer (LbL) technique.5,6
Nanostructured PEMs combine multiple functionalities to
provide control over cargo release: their shell permeability
could be changed by external triggering using either an altered
environment (pH, osmolarity) or a physical stimulus (light,
temperature, or ultrasound).7–10 A broad range of functional
properties, together with a relatively small size of capsules
(nano- to micrometer range), ultimately provided such cargo
systems with numerous benefits, prompting growing interest
towards translating fundamental studies into practical
implementations.3,8,11,12 Whilst successful encapsulation has
been implemented for a wide variety of substances,13 micro-
scopic targeting of cargo release along predetermined space
trajectories or geometric patterns has remained elusive. This
targeting could be particularly important, for instance, for
guiding cell growth or dealing with geometrically defined
tissue areas.
Recent advances in PEM films fabricated on patterned sur-
faces appear to overcome the issue of capsule scattering, by
enabling an array of micro-wells or microchambers of pre-
determined size and spatial distribution.5,6,14 Composed as
LbL-assembled PEM films, this novel strategy of housing bio-
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active compounds combines all functionalities of PEM nano-
structures with having a layer of hydrophobic polymer such as
polylactic acid (PLA) to increase load capacity. The eﬃcient
entrapment and storage of various compounds in PEM micro-
chambers have recently been demonstrated,15,16 including the
use of wall nanocomposites sensitive to external triggering for
payload release.14,17 Clearly, the predetermined patterns of
microchambers could provide an opportunity to control the
localised release of active compounds in space, time, and
dosage. Films containing microchambers could also be de-
posited as a microscopic coating on the surfaces of stents or
implants. It would seem therefore important to understand
whether and how this delivery system can be used in the con-
ditions of live cells and their networks.
To address this issue, we grew human N2A cells diﬀerentiat-
ing to neuronal phenotype on the surface of either
PEM@polylactic acid (PLA)-based or PLA-based films to test
biocompatibility (neurotoxicity) and safe preservation of low
molecular weight substances as the cargo inside the square
grid distributed microchambers for up to two weeks in vitro.
We probed the eﬃcient release of the cargo, the excitatory
neurotransmitter glutamate, using a focused laser beam and
established the glutamate-induced physiological eﬀects on the
adjacent N2A cells. Our results provide evidence for the safe
and eﬃcient use of the fabricated microchamber arrays for a
pharmacological action on human cells.
Methods
Fabrication of microchamber arrays
Patterned microchamber array production was performed as
detailed in our previous studies,6,14,15,17,18 with some modifi-
cations. Generally, a patterned microchamber array was com-
posed of two nanocomposite films (Fig. 1A and B), each
printed separately and joined after loading a cargo (Fig. 1C).
The first film represents a patterned layer containing micro-
wells, while the second is flat, without wells, made of the same
composite materials.
Patterned PDMS stamps. To fabricate patterned films with
micro-wells, poly(dimethylsiloxane) (PDMS) stamps were used
(Sylgard 184, Dow-Corning, Midland, USA). PDMS stamps were
printed out from silicon masters with micropillars. For this, a
mixture of a pre-polymer and a curing agent was prepared in a
ratio of 10 : 1 and poured on silicon masters, then degassed in
a vacuum for 30 min and cured at 70 °C for 3 h. The silicon
master was prepared by conventional photolithography. The
fabricated micropillars had a cylindrical shape of 10 μm in dia-
meter and 5 μm height.
PEM@PLA and PLA production. Diﬀerent types of micro-
chamber arrays were fabricated, variable by the nanocomposite
assembly (PEM@PLA and PLA) and/or the cargo payload
(glutamate and its analogue, fluorescent dyes, or empty ones
(no payload)), for further functional testing of either array.
PEM films were fabricated with the LbL assembly method,5,6
using a dip-coating robot. Before starting, both PDMS stamp
and cover glass (for a flat film production) were submerged in
a positively charged poly(ethylenimine) (PEI, Sigma, St Louis,
USA) solution for 10 min, followed by washing with ddH2O 3
times for 1 min each. Subsequently, two opposite-charged
polyelectrolytes, poly(sodium 4-styrenesulfonate) (PSS, Sigma,
St Louis, USA) and poly(diallyldimethylammonium chloride)
(PDDA, Sigma, St Louis, USA), were layered with the same pro-
cedure. Either compound was used at the concentration of
2 g L−1 (in 0.5 M NaCl) for each layer. In total, 40 layers of
PSS/PDDA were applied on the PDMS stamp and 20 layers of
PSS/PDDA on the cover glass. For hydrophobization, the PEM
films were immersed in 0.5% polylactic acid (PLA, 3 mm
nominal granule size, Sigma, St Louis, USA) for 3 s and dried
afterwards (typically, 10 min in air) (Fig. 1A). For fabrication of
the PLA-based films, the procedure includes the immersion of
both the PDMS stamp and the cover glass in a 0.75% PLA solu-
tion for 3 s, followed by drying (Fig. 1B).
Cargo loading and microchamber sealing. Several water-
soluble, low molecular weight substances were loaded inside
the microchambers, including fluorescent dyes (FITC, rhoda-
mine) and the most common excitatory neurotransmitter glu-
tamate (glutamic acid or its pharmacological analogue,
L-glutamic acid hydrochloride). Each compound was diluted at
a required concentration (near its maximal solubility) and
applied onto the surface of the patterned film to fill micro-
wells. The compound concentration was as follows: 0.5 μg ml−1
for rhodamine and FITC (Sigma, St Louis, USA), 10 μg ml−1 for
glutamic acid, and 300 μg ml−1 for L-glutamic acid hydro-
chloride (Sigma, St Louis, USA). After filling the micro-wells
with the solution, the film was allowed to dry until cargo crystals
were formed (Fig. 1D). Finally, the patterned microfilm with the
crystals inside the microchambers was sealed to a flat film with
a pressure (−2 kg cm−1) to make one single unit (Fig. 1C).
To optimise filing of the microchambers, L-glutamic acid
hydrochloride (diluted at 300 μg ml−1 in ddH2O) was applied
onto the patterned film surface in 200–300 μl volume batches
to fill all microchambers across a sample; the remaining
medium was then carefully removed from the film surface
(a process facilitated by the hydrophobic PLA surface). As a
result, large crystals of L-glutamic acid hydrochloride (clearly
visible at a magnification of ×20 and above) were filling the
microchambers homogeneously across the sample and, impor-
tantly, were of a similar size between the microchambers, as
evidenced by SEM images (Fig. 1D). Such a controlled cargo
payload for individual microchambers is essential for further
functional testing on live cells. The estimated amount of
L-glutamic acid hydrochloride was ∼20 pg per microchamber.
Scanning electron microscopy (SEM)
Scanning electron microscopy (SEM, FEI, Inspect-F) was used
to visualize the microchamber morphology at diﬀerent steps
through the fabrication procedure (payload, sealing) and after
opening the microchamber(s) to ensure appropriate samples.
SEM was carried out using an accelerating voltage of 10 kV, a
spot size of 3.5 nm, and a working distance of approximately
10 mm.
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Fig. 1 Fabrication of polymer microchamber arrays containing low molecular weight substances as a cargo payload. (A) Fabrication of the
PEM@PLA nanocomposite assembly: two ﬁlms, patterned and ﬂat, each printed separately, before sealing together to compose polymer micro-
chambers. (B) For the PLA-based microchamber arrays, the fabrication process includes production of the patterned ﬁlm with the microchambers
and the ﬂat ﬁlm on a glass, which are then sealed together. (C) A schematic depicting the sealed microchamber array, with a cargo payload within
the microchambers. (D) SEM images of the microchambers (before sealing) for the various types of the fabricated polymer arrays: empty micro-
chambers (no cargo; left image) and microchambers ﬁlled with glutamic acid (at the middle) or L-glutamate hydrochloride (right image). Red arrows
show a cargo crystal per microchamber. Scale bars, 10 μm.
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Human N2A cell line, a gift from the Prof. Stephen Hart’s
group (UCL, UK), was cultured in Dulbecco’s modified Eagle
medium (DMEM, Invitrogen, Carlsbad, CA, USA), containing
high glucose and 2 mM L-glutamine, supplemented with 10%
fetal bovine serum (FBS), 2% penicillin–streptomycin, and 1%
non-essential amino acids at 37 °C (5% CO2). The cells were
harvested using 0.05% trypsin–EDTA (Gibco, USA) for
5–10 min, washed and plated on the surface of microchamber
arrays placed individually in a 5 cm2 Petri dish. The fabricated
microchamber arrays were pre-treated with UV light for at least
2 h prior to plating the cells. For diﬀerentiation of the N2A
cells to neuronal phenotype, the culturing medium was low
serum DMEM (2% FBS instead of 10%). The diﬀerentiating
N2A cells were maintained on the microchamber array
samples until used. For each type of the microchamber arrays,
there were at least three independent cell preparations tested.
Cell viability assessment
To monitor possible concomitant toxic eﬀects of the microcham-
ber arrays, we compared the density of the N2A cells growing on
the surface of the PEM@PLA- and PLA-based arrays with that of
those growing outside the microchamber area, at various time
points of cell growth. Healthy cells were counted within the
sampling areas chosen in a quasi-random fashion in the middle
of the microchamber arrays, and outside the microchamber area
(close to the film edge). Cell density was calculated as the
number of viable cells per mm2. An additional control group
included N2A cells plated on glass coverslips, with no polymer
(PLA) present. The other functional indicator of cell viability was
the total length of cell neurites per cell. To this end, cell images
(sampled as above) were analysed with NeuronJ (ImageJ, NIH).
Opening of individual microchambers with a femtosecond
pulse laser
To optically address individual microchambers, we employed a
Femto2D (Femtonics) multi-photon excitation microscope
system optically linked to a Ti:Sapphire Mai-Tai femtosecond
pulse laser (SpectraPhysics, Newport, ∼220 fs pulses at
80 MHz). The two key advantages of two-photon (2P) excitation
(or absorption) with near-infrared light were (i) high pene-
tration (low scattering and absorption) in turbid media com-
pared to visible or UV light and (ii) the 2P excitation eﬀect
within a thin (∼1 µm) focal layer only. Another important
advantage of femtosecond-pulse excitation in live tissues was
that, despite a very high intensity delivered during the pulse,
the time-average wattage delivered to the specimen was fully
compatible with live function. Indeed, the range of laser power
used here was similar to that routinely used by us and others
for cell imaging in acute brain slices and in live animals.19–21
The empirically determined optimal wavelength was
740 nm (opening of the PEM@PLA films) or 780–790 nm
(opening of the PLA-based microchambers). For micro-
chamber opening, the laser beam was focused on the top of
the microchamber cap (typically, within the cap edges), at a
power of 26 mW over 3–5 ms. We ensured that no neighbour-
ing cells were aﬀected by the high-power laser pulses during
microchamber opening, as evidenced by the images shown.
Otherwise, cell imaging was carried out at a power under the
objective of <3 mW, as detailed below. We found that the two
protocols for microchamber formation, PEM@PLA and PLA,
work equally well for cargo (glutamate) loading and for laser
opening. Thus, the presence of the precursor PEM film did not
appear to have an eﬀect on the microchamber functionality,
which was defined largely by the terminated PLA layer.
Two-photon (2P) excitation fluorescence imaging. Cells were
bolus loaded with the cell-permeable Ca2+ indicator Oregon
Green BAPTA-1 (OGB-1 AM; 5 µM, Invitrogen) in the presence
of Pluronic F-127 (0.02%, Invitrogen) by incubation for
30 minutes at 37 °C. After loading, the cells were washed for
approximately 30 minutes for de-etherification of the dye.
A sample was placed in a recording chamber mounted on the
stage of an Olympus BX51WI upright microscope (Olympus,
Japan) equipped with an XLPlanN 25×/1.05 objective coupled
to an infrared DIC imaging system. Imaging was carried out
using a Femto2D (Femtonics, Budapest, Hungary) system opti-
cally linked to a Ti:Sapphire Mai-Tai femtosecond pulse laser
(SpectraPhysics, Newport), and excitation at λ2Px = 800 nm opti-
mized for OGB-1. To minimize contaminating fluorescence
(PEM/PLA autofluorescence), 2P excitation fluorescence
images were taken from a thin focal excitation plane (∼1 µm)
within individual cells, which was held unchanged throughout
the experiment (prior to and following opening a microcham-
ber). For the time-lapse changes in OGB-1 fluorescence,
images were collected using 512 × 512 pixel frames in the
stream acquisition mode acquired in 20 s time sections for
typically 1 minute before opening a microchamber (baseline)
and for 2.5–5 min immediately after the microchamber
opening. Changes in [Ca2+]i were expressed as the changes in
OGB-1 fluorescence at the maximum of the fluorescent signal
over the baseline (ΔF/F0), as detailed previously.22
The sequence of laser-triggered microchamber opening
(pulse 3–5 ms, 1–2 times; λ = 790 nm), including focal adjust-
ment and fast scanning in line mode to identify opening, took
typically ∼30 s. Recordings were carried out in a HEPES-based
medium containing (in mM) 135 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2,
10 HEPES, 10 glucose (pH 7.4; 290–300 mOsm). In a separate
set of experiments, glutamate (5 μM) was locally applied to the
cells via a fabricated glass micropipette (∼1 µm inner diameter
of the tip) to provide a direct comparison of the eﬀects between
the triggered release of cargo from the microchambers and the
locally applied agonist. To enable a brief, localised agonist
application (200–400 ms duration), a pressurised micropipette
was connected to the two-channel PDES-02DX pneumatic
microejector (npi electronic GmbH) with compressed nitrogen.
The fluorescent tracer Alexa Fluor-594 (100 µM) was added into
the pipette to visualize the area of the agonist spread.
Time-resolved fluorescence lifetime imaging (FLIM)
In the context of intracellular Ca2+ monitoring, fluorescence
lifetime imaging (FLIM) can provide readouts insensitive to
Paper Biomaterials Science






















































































concomitant fluctuations in focus or in dye concentration.21,23,24
FLIM was conducted using the in-house system based on the
Femto2D microscope equipped with a Becker and Hickl FLIM
detector (Femtonics, Budapest), as described earlier.21,23 The
FLIM duty cycle was driven by an 80 MHz infrared pulsed laser
(SpectraPhysics, Newport Mai-Tai BB). Fluorescence images
were acquired at 2 frames per second and stored as a data
tensor representing x-y pixel images with a distribution of the
nanosecond delay time (t ) of photons at each pixel over the
frame duration (T ). Average image acquisition times were
240–300 s (maximum frame laser exposure time per acqui-
sition trial of <6 s to minimize phototoxic damage), depending
on the total photon count; the maximum photon count rate
was on average <105 s−1 which is well below the eﬀect of
photon pile-up. To monitor changes in [Ca2+], we minimized
the sampled image area with various digital zooms to approxi-
mately 70 × 70 μm (x, y). Because of the relatively low photon
counts per pixel, the photon data were accumulated over the
selected ROI from the (t, x, y, T ) tensor into the (t, T ) matrix
before the data analysis was used to estimate [Ca2+]. To
confirm changes in the OGB-1 fluorescence intensity, we also
calculated the intensity from FLIM data, by integration of the
photon counting data (non-normalized) at the same ROI
(Fig. 6A).
Statistical analysis
All data are presented as mean ± standard error of the mean,
with n referring typically to the number of cells analyzed
within the experimental groups. For the cell viability analysis,
n refers to the number of diﬀerent areas/samples where the
cell density was assessed or indicates the number of neurites
measured for their length. To determine statistical diﬀerence
between the experimental groups, Student’s t-test (two-tailed
paired or unpaired) was used where appropriate. A p value of
less than 0.05 was considered as statistically significant.
Results and discussion
Biocompatibility and cargo preservation
The neuroblastoma cell line (N2A) was selected to provide fast
cell growth, with the cells diﬀerentiating to neuronal
phenotype.25–28 We placed the stamped arrays of microcham-
bers (Fig. 1) filled with either glutamate or fluorescent indi-
cator, or left empty, in the cell culture medium, and sub-
sequently plated the N2A cells to grow on the array surface, or
entirely outside the arrays, during 7–10 days (Methods). The
two array types tested were PEM@PLA (Fig. 2) and PLA (Fig. 3).
24 h post plating, the N2A cells developed typical axon-like
processes and extended neurites (e.g., Fig. 2B and 3B). To
assess cell viability, we monitored the length of such pro-
cesses, along with the cell density, throughout the preparation,
for up to ten days in vitro (Methods). During that time, cell pro-
cesses could reach up to 300 µm in length, suggesting no gross
detrimental eﬀects of having the fabricated arrays nearby. On
a finer scale, we found no diﬀerence in the cell viability among
the samples containing microchambers, with or without
loaded glutamate, inside or outside the chamber areas (or with
no polymer material present), for both array fabrication types,
over 3–7 days in vitro (Fig. 2C and 3C). This observation is con-
sistent with the reported biocompatibility of the constituent
polymers, PSS and PLA.29,30 Also, given that the diﬀerentiating
N2A cells are highly sensitive to low glutamate levels,25,31 this
result also suggests the microchamber wall stability in prevent-
ing cargo escape.
Localised cargo release by optical targeting of individual
microchambers
Next, we used laser pulses to open individual microchambers
at selected sites (Methods). We thus tested varied beam trajec-
tories (line, spiral, point) to open individual microchambers
across the polymer surface, also exploring varied exposure
areas (from 1 to 5 μm; Fig. 4). The successful opening of the
targeted microchambers, with fully intact neighbours, was
confirmed with SEM (Fig. 4B and D). Importantly, cultured
N2A cells nearby remained unperturbed (Fig. 5 and 6). We next
tested whether the payload inside the microchambers
remained intact after loading and optical addressing (laser
beam opening). First, we used a fluorescent dye, either rhoda-
mine or FITC, as the cargo. The presence of fluorescent emis-
sion inside the microchambers was confirmed using 2P exci-
tation imaging at the plane of microchambers, for either
loaded dye (Fig. 4A for rhodamine and Fig. 5 for FITC). We
were also able to visualise the release of the loaded dye upon
microchamber opening, using the time-lapse imaging: a
prompt and robust rise in the FITC-mediated fluorescence
next to the opened microchamber could be detected over the
regions of interest (ROIs, indicated in Fig. 5A and C) shortly
after the laser pulse (Fig. 5B and D). Appearance of an air
bubble (transmitted light channel) immediately after the pulse
indicated microchamber opening (Fig. 5A and C), as reported
in previous studies.15 Control experiments confirmed that
there was no rise in FITC fluorescence (no payload release)
over the same ROI when no laser pulse was applied (Fig. 5B
and D) or when repeatedly targeting the opened micro-
chamber. Subsequent targeting of the intact microchambers
triggered a similar rise in local FITC fluorescence over the
neighbour area (Fig. 5C and D), confirming the repeatable
eﬀect on demand.
Laser-triggered glutamate release from individual
microchambers mobilises intracellular Ca2+ in local N2A cells
Finally, we evaluated functional eﬀects of the triggered cargo
release on live cells. To this end, we used glutamate-loaded
microchambers: in N2A cells, glutamate induces a prominent
inward current through the Ca2+-permeable N-methyl-D-aspar-
tate (NMDA) receptors.32 We therefore employed 2P excitation
imaging of the Ca2+ indicator Oregon Green BAPTA-1 (OGB-1)
bulk-loaded into the diﬀerentiated N2A cells growing (3–6 days)
on the microchamber arrays filled with glutamate (L-glutamic
acid hydrochloride, Methods; Fig. 1D). Imaging was carried
out in continuous frame-scanning mode (∼500 ms per frame),
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Fig. 2 Biocompatibility and cargo preservation within the microchambers: the fabricated PEM@PLA microchamber arrays. (A) Transmitted light
images of PEM@PLA-patterned microchamber arrays, central area (left) and towards the edge, depicting the detached PEM ﬁlm (right). Scale bars,
50 μm. (B) Representative images of the diﬀerentiating N2A cells growing on the surface of the microchambers loaded with glutamic acid (left row)
or outside the microchamber area (right row) at diﬀerent time points after cell plating. Green arrows, axon-like processes in the N2A cells of neuro-
nal phenotype. Scale bars, 15 μm. (C) Statistical summary, cell density (mean ± s.e.m.) on top of the microchambers loaded with glutamate (left) and
outside the microchambers (right), at three days in vitro (DIV3) and DIV6–7; n, number of sampled areas; p, two-tailed, unpaired t-test.
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Fig. 3 The diﬀerentiating N2A cells show no signs of excitotoxicity when growing on the PLA-based microchamber arrays with the glutamate
payload. (A–B) The representative transmitted light image (A) and SEM images (B) of the PLA-based microchamber array after sealing the micro-
chambers with loaded glutamic acid inside. Scale bars in B, 10 μm. (C) Representative snapshots of the diﬀerentiating N2A cells growing on the
surface of the PLA-based microchambers loaded with glutamate (left panels) and outside the microchamber area (right panels) at diﬀerent times
after cell plating. Green arrows, axon-like processes in the N2A cells of neuronal phenotype. Scale bars, 15 μm. (D)A snapshot of the diﬀerentiating
N2A cells on a glass coverslip at DIV3. Plots, statistical summary, cell density (left) and neurite length (right, mean ± s.e.m.) for the cells growing on
the coverslips, the PLA-based microchambers containing glutamate, in the area outside microchambers; n, number of sampled areas (left) or
measured neurites (right); p, two-tailed, unpaired t-test.
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Fig. 4 Optical targeting of individual microchambers with a femtosecond infrared pulse. (A) Images of the PEM@PLA-microchambers (transmitted
light, TL, and rhodamine ﬂuorescence channels, λ2Px = 800 nm) before and after applying a focused laser beam (λ = 740 nm) for opening the selected
microchambers, using various trajectories (line or spiral) as indicated. Red arrows depict the pattern applied to open a microchamber. Scale bars,
10 μm. (B) SEM images of the microchamber morphology after opening with a femtosecond pulse laser. Images are taken from the same area as for
the bottom row in A (microchambers match), showing successful opening with various patterns of a laser beam applied to the microchamber
surface. Red arrows, patterns used for opening. Scale bars for bottom images, 5 μm. (C) Transmitted light images of the PLA-based microchamber
arrays before and after applying a femtosecond pulse laser for microchamber opening (spiral trajectories, 3 μm wide). (D) SEM images of the opened
microchamber, indicated in the top snapshot, using a line segment laser trajectory. Scale bars, 10 μm.
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before opening a microchamber (baseline) and immediately
afterwards (up to several minutes; Fig. 6A). The chamber
opening phase, including line scan (top middle image in
Fig. 6A) and focal adjustment, took ∼30 s (Methods). In the
proximity of the glutamate-filled microchambers, we could
detect clear Ca2+ rises inside the cells following local micro-
chamber opening. The rises were transient and declined back
close to the resting baseline level within minutes of micro-
Fig. 5 Release of the ﬂuorescent cargo from individual microchambers using optical targeting. (A) The PEM@PLA microchamber array with the
FITC payload in microchambers (transmitted light, TL, and FITC ﬂuorescence channels; λ2Px = 800 nm), before (top), during (middle), and after
(bottom) optical targeting of a microchamber with a femtosecond laser beam (λ = 790 nm; 26 mW, 3 consequent pulses, for 5 ms each). An air
bubble formed upon the laser pulse conﬁrms the microchamber opening. Scale bars, 10 μm. (B) Time course of changes in FITC ﬂuorescence over
regions of interest (ROIs), as indicated in A. (C) The same PEM@PLA microchamber array as for A and B (FITC payload) while targeting another micro-
chamber. Air bubble formation conﬁrms the microchamber opening, followed by visualization of the opened (disﬁgured) microchamber. Scale bars,
10 μm. (D) Time course of changes in FITC ﬂuorescence over various ROIs, as indicated in C.
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Fig. 6 Monitoring the intracellular Ca2+ rise in the diﬀerentiating N2A cells upon the triggered release of glutamate from the microchambers.
(A) An example of a diﬀerentiated N2A cell grown on the PLA-based microchamber array loaded with glutamate before (left) and after (right) local
microchamber opening (dotted line). Upper row, transmitted light images; bottom row images, the OGB-1 ﬂuorescence channel (λ2Px = 800 nm).
Middle panel, line scan across the dotted line as shown in the left image, conﬁrming the microchamber opening with a femtosecond pulse laser
(λ = 790 nm; 26 mW); scale bars, 10 μm. Plots, time courses of the OGB-1 ﬂuorescence intensity signal ΔF/F (left) and of [Ca2+]i (FLIM readout, right),
during chamber opening, as indicated. (B) Left panels: A DIC image (top) and OGB-1 channel snapshot (bottom); dotted areas, ROIs 1 and 2, for the
soma and neurites, respectively; red arrow, the targeted microchamber. Plots: time course of the Ca2+ rise in the cell soma (ROI 1) and neurites
(ROI 2), during the glutamate release from a microchamber, as indicated. (C) Statistical summary. Left, [Ca2+]i levels in the N2A cells before and
following microchamber opening (FLIM readout, n = 14 cells). Right, relative changes in OGB-1 ﬂuorescence intensity in response to optical target-
ing of the PLA-based microchambers with no payload (empty) and loaded with glutamate (red); n, the total N2A cells analysed across four inde-
pendent experiments for each type of fabricated arrays. ***, p < 0.0001 (two-tailed, paired and unpaired t-test for left and right plots, respectively).
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chamber opening (Fig. 6A, bottom). The time course of the
Ca2+ rise detected in the N2A cell soma and neurites displayed
comparable kinetic profiles (Fig. 6B). The functional eﬀect was
measured in 102 cells growing on top of the glutamate-loaded
microchambers to be tested for opening (about 22 microcham-
bers in total) across 4 PLA-microchamber array samples (n = 4
independent cell culture preparations; Fig. 6C). In contrast,
there were no detectable changes in Ca2+ dynamics in the
Fig. 7 Monitoring [Ca2+]i dynamics in the adjacent N2A cells upon the triggered release of glutamate from individual microchambers.
(A) Transmitted light (top) and ﬂuorescence images (bottom, OGB-1 ﬂuorescence channel; λ2Px = 800 nm) of the diﬀerentiating N2A cells growing on
the surface of the PLA-based microchambers loaded with glutamate before and after opening the selected microchamber. Red arrow, a micro-
chamber before and after opening. Plots, time course of changes in OGB-1 ﬂuorescence intensity for individual cells as shown in the bottom left
image. (B) Experiment as in A, but monitoring [Ca2+]i in the N2A cells using the OGB-1 FLIM readout. Scale bars, 10 μm.
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Fig. 8 Replicating the functional eﬀect of the glutamate release from the microchambers with a focal agonist application onto the N2A cells.
(A) Summary of the Ca2+ rise in individual N2A cells (n = 102) in response to the triggered glutamate release from the microchambers, plotted
against the distance from the targeted microchambers. (B) Images of the diﬀerentiating N2A cells growing on the surface of the PLA-based micro-
chamber array before (top) and after (bottom) a direct focal application of glutamate (5 μM, 200 ms duration) through a micropipette positioned in
the close proximity of the cells. Images, combined transmitted light, OGB-1 (green), and Alexa Fluor-594 (red) channels (λ2Px = 800 nm). (C) The
same area as in A, showing the N2A cells at the OGB-1 ﬂuorescence channel (λ2Px = 800 nm); regions of interest (ROIs) are shown; red arrow,
glutamate puﬀ through the micropipette (dotted lines). Bottom plots, time course of the Ca2+ rise over indicated ROI before and after glutamate
application (5 μM, 200 ms); red arrow, timing of glutamate puﬀ.
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N2A cells growing on the surface of the PLA arrays containing
empty microchambers (no payload), upon their opening (n =
33; p < 0.001 compared with the group of cells on the gluta-
mate-containing microchambers; Fig. 6C).
To verify that the observed Ca2+ transients were within the
physiological range and not aﬀected by focus fluctuations, cell
deterioration, or concomitant laser pulse eﬀects, we used a
FLIM method to document the ‘absolute’ intracellular Ca2+
concentration ([Ca2+]i) dynamics, as shown earlier.
21,23 Thus,
we obtained the direct readout of the intracellular Ca2+ con-
centration ([Ca2+]i) in the N2A cells before and after opening
the microchambers (Fig. 6A bottom). Our data demonstrated a
low resting [Ca2+]i in the diﬀerentiated N2A cells (mean [Ca
2+]i
value: 83 ± 8 nM, n = 14 cells; Fig. 6C), a fully relevant physio-
logical level similar to the neuronal [Ca2+]i reported in situ.
21,33
Glutamate release from the microchambers triggered a rapid
[Ca2+]i rise, in the 200–400 nm range, in each of the analysed
cells (p < 0.001; Fig. 6C), which is consistent with the Ca2+
dynamics in neurons in vivo.19
Finally, to assess how far the released glutamate can spread
following triggered microchamber opening, we monitored the
[Ca2+]i dynamics in N2A cells located at diﬀerent distances
from the targeted microchamber. We found transient changes
in [Ca2+]i (somata) only in cells located at <50 μm from
the opened microchamber, across the targeted areas (Fig. 7
and 8A). Again, the functional eﬀect could be detected using
the OGB-1 fluorescence readout (Fig. 7A) and FLIM measure-
ments (Fig. 7B). This was fully compatible with the spatial
eﬀects of glutamate which was applied via a pressurized micro-
pipette (5 μM glutamate, Methods), with the fluorescent
control of the puﬀ (Alexa Fluor-594 inside the micropipette;
Fig. 8B). These recordings demonstrated a prompt, site-
specific [Ca2+]i rise in diﬀerentiated N2A cells whose dynamics
depended on the localization of cells towards the site of
agonist release (Fig. 8C). It is noteworthy that, with a suitable
adaptation of the microchamber properties, their opening
could be, in principle, enacted along a moving trajectory of
laser pulses, thus enabling a more comprehensive space–time
control of substance release.
Conclusions
The present study provides experimental evidence indicating
that the fabricated polymer microchamber arrays (PEM- and/or
PLA-based) could be an eﬃcient drug delivery system for the
site-specific, geometry-bound targeting of human cells.
Human N2A cells of neuronal phenotype, a highly environ-
ment-sensitive cell type, showed no detectable toxicity eﬀects
when grown on the PEM@PLA- or PLA-based film surfaces
over at least ten days. This suggested (a) high biocompatibility
of the film material and (b) reliable drug retention (no
leakage) over days. One important advantage we observed was
the successful optical addressing of individual microchambers
with a focused laser beam, providing site targeting on the
micron scale, without employing gold or other light-absorbing
nanoparticles normally required to facilitate microchamber
opening. Thus, having the precursor PEM film did not appear
essential in microchamber fabrication, in the context, which
should facilitate the fabrication process.
As a proof-of-concept, this study also demonstrates func-
tional eﬀects triggered by cargo release in live human cells of
neuronal phenotype. The action was localised and repeatable
on demand and could be reproduced by local puﬀ application
of the cargo. Further studies will be required to address the
operational capability of polymer patterned arrays within
organised tissue, in situ and in vivo, for their potential
implementation towards controlled drug delivery throughout
the tissue suitable for various therapeutic interventions.
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